Skip to content
Ranked #115Desk pick
SkinnyRx

A tablet route on either molecule; anyone shopping tirzepatide month to month should compare $299/mo, not the $99 first month, and semaglutide buyers should get the renewal price in writing first.

semaglutide
$99intro + renewal; see terms
tirzepatide
$299/mo

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

vs
Ranked #170
TeleCareSpot

Flat-priced compounded semaglutide or tirzepatide with broad state coverage.

semaglutide
$299/mo+ membership fee
tirzepatide
$399/mo
Before enrolling

The published LegitScript seal ID, #45936855, did not resolve at our last documented check; current certification status remains unconfirmed

Our review of SkinnyRx gives it 74/100 (C), while our review of TeleCareSpot gives it 71/100 (C). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

SkinnyRx

74/100

C

Overall

TeleCareSpot

71/100

C

Price transparency

48
46

State access

86
78

Molecule range

92
77

Onboarding speed

80
78

Support responsiveness

80
76

Licensing & trust

62
93

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldSkinnyRxTeleCareSpot
Semaglutide$99intro + renewal; see terms
Full plan terms

$99 first month (no renewal price is printed on its public pages; compounded injection; semaglutide tablets $149 first month, also with no renewal price printed)

$299/mo+ membership fee
Full plan terms

$299/mo (all doses, plus a separate fee, compounded)

Tirzepatide$299/mo
Full plan terms

$299/mo month-to-month (first month $99; $289/mo on 4 months, $250/mo on 6 months, $225/mo on 12 months; compounded; tablets the same after a $199 first month, with a 3-month plan in place of the 4-month one; whether longer plans are charged up front is not stated on its public pages)

$399/mo
Full plan terms

$399/mo

Coverage47 states + DC (not Alabama, Louisiana or Mississippi)48 states
Brand-nameNot confirmed hereNot confirmed here
Oral optionOral option listedOral option listed
Best forA tablet route on either molecule; anyone shopping tirzepatide month to month should compare $299/mo, not the $99 first month, and semaglutide buyers should get the renewal price in writing first.Flat-priced compounded semaglutide or tirzepatide with broad state coverage.
Desk Score74/100C71/100C

The verdict

Desk pick — SkinnyRx

SkinnyRx has the higher Desk Score, but TeleCareSpot may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose SkinnyRx if…

A tablet route on either molecule; anyone shopping tirzepatide month to month should compare $299/mo, not the $99 first month, and semaglutide buyers should get the renewal price in writing first.

$99 (intro + renewal; see terms) sema · $299/mo tirz · 47 states + DC (not Alabama, Louisiana or Mississippi)

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

Choose TeleCareSpot if…

Flat-priced compounded semaglutide or tirzepatide with broad state coverage.

$299/mo (+ membership fee) sema · $399/mo tirz · 48 states

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.